Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer

Oncotarget

Volumn 6, Issue 38, 2015, Pages 40575-40587

  Rodríguez, Marta ^a   Silva, Javier ^a   Herrera, Alberto ^a   Herrera, Mercedes ^a   Peña, Cristina ^a   Martín, Paloma ^a   Gil Calderón, Beatriz ^a   Larriba, María Jesús ^b   Coronado, Ma José ^a   Soldevilla, Beatriz ^a,c   Turrión, Víctor S ^a   Provencio, Mariano ^a   Sánchez, Antonio ^a   Bonilla, Félix ^d   García Barberán, Vanesa ^a,e  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c CSIC   (Spain)

^d Centro de Estudios Biosanitarios   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Breast cancer; Exosomes; Liquid biopsy; MRNA; Stemness and metastasis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; NUCLEIC ACID; CXCR4 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXOSOME; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BREAST TUMOR; CANCER STEM CELL; CELL MOTION; CELL TRANSFORMATION; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84951032501     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5818     Document Type: Article

References (26)

1. Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Research. 2011; 71:3792-3801.
2. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Review. 2013; 32:623-642.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013; 63:11-30.
4. Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease. Journal of Cellular and Molecular Medicine. 2008; 12:374-390.
5. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414:105-111.
6. Shekhani MT, Jayanthy A-S, Maddodi N, Setaluri V. Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies. American Journal of Stem Cells. 2013; 2:52-61.
7. Clarke MF. Oncogenes, self-renewal and cancer. Pathologie Biologie (Paris). 2006; 54:109-111.
8. Chiang AC, Massagué J. Molecular basis of metastasis. The New England Journal of Medicine. 2008; 359:2814-2823.
9. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clinical Cancer Research Off Journal American Association for Cancer Research. 2010; 16:2927-2931.
10. Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EGE, Walenkamp AM. A review on CXCR4/CXCL12 axis in oncology: no place to hide. European Journal of Cancer Oxf Engl 1990. 2013; 49:219-230.
11. Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia. 2009; 23:43-52.
12. Ablett MP, O'Brien CS, Sims AH, Farnie G, Clarke RB. A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity. Oncotarget. 2014; 5:599-612.
13. Liao W-T, Ye Y-P, Deng Y-J, Bian X-W, Ding Y-Q. Metastatic cancer stem cells: from the concept to therapeutics. American Journal of Stem Cells. 2014; 3:46-62.
14. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Research. 2009; 69:1302-1313.
15. Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Research BCR. 2011; 13:215.
16. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133:704-715.
17. EL Andaloussi S, Mäger I, Breakefield XO, Wood MJA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nature Review Drug Discovery. 2013; 12:347-357.
18. Floor S, van Staveren WCG, Larsimont D, Dumont JE, Maenhaut C. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene. 2011; 30:4609-4621.
19. Wu K-J, Yang M-H. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosciences Reports. 2011; 31:449-455.
20. Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. OncoTargets and Therapy. 2013; 6:1347-1361.
21. Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research. 2011; 71:603-613.
22. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research BCR. 2009; 11:R46.
23. Xu T-P, Shen H, Liu L-X, Shu Y-Q. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a metaanalysis. Cancer Epidemiology. 2013; 37:725-731.
24. Fernández-Periáñez R, Molina-Privado I, Rojo F, Guijarro-Muñoz I, Alonso-Camino V, Zazo S, Compte M, Alvarez-Cienfuegos A, Cuesta AM, Sánchez-Martín D, Alvarez-Méndez AM, Sanz L, Alvarez-Vallina L. Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis. PloS One. 2013; 8:e72957.
25. Mannello F. Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm. BMC Medicine. 2013; 11:169.
26. Soldevilla B, Rodríguez M, San Millán C, García V, Fernández-Periañez R, Gil-Calderón B, García-Grande A, Silva J, Bonilla F, Domínguez G. Tumor-derived exosomes are enriched in ßNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival. Human Molecular Genetics. 2014; 23:467-478.